Alnylam's RNAi therapeutic Onpattro for polyneuropathy of hATTR amyloidosis receives first approval Aug. 13, 2018
Petrovax Pharm's 4-valeant influenza vaccine --Grippol Quadrivalent-- approved in Russia Aug. 10, 2018